LEADER 02937nam  2200709   450 
001 9910787593503321
005 20230803030605.0
010   $a1-78084-327-5
010   $a1-78084-222-8
035   $a(CKB)2670000000391297
035   $a(EBL)1179652
035   $a(OCoLC)851970667
035   $a(SSID)ssj0001599936
035   $a(PQKBManifestationID)16306450
035   $a(PQKBTitleCode)TC0001599936
035   $a(PQKBWorkID)14892880
035   $a(PQKB)10368831
035   $a(SSID)ssj0001599982
035   $a(PQKBManifestationID)16306727
035   $a(PQKBTitleCode)TC0001599982
035   $a(PQKBWorkID)14892444
035   $a(PQKB)11405068
035   $a(MiAaPQ)EBC5092475
035   $a(MiAaPQ)EBC1179652
035   $a(Au-PeEL)EBL5092475
035   $a(CaPaEBR)ebr11451923
035   $a(OCoLC)851776810
035   $a(Au-PeEL)EBL1179652
035   $a(EXLCZ)992670000000391297
100   $a20220517d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aMonoclonal antibodies in oncology /$feditor, Fatih M. Uckun
205   $a1st ed.
210  1$aLondon, England :$cFuture Medicine Ltd.,$d[2013]
210  4$dİ2013
215   $a1 online resource (85 p.)
225 0 $aFuture Medecine,$x2047-332X
300   $aDescription based upon print version of record.
311   $a1-78084-329-1 
311   $a1-78084-224-4 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aTitle page; Copyright page; Contents; Foreword. Monoclonal antibodies in contemporary cancer therapy; 1. mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment; 2. mAbs targeting CTLA-4 and clinical outcomes; 3. mAbs targeting VEGF/VEGFR and clinical outcomes in cancer treatment; 4. mAbs targeting RANKL in bone metastasis treatment; 5. Novel monoclonal antibody-based therapies for leukemia; Index
330   $aMonoclonal antibodies (mAbs) have been developed to improve the treatment outcome of cancer patients undergoing therapy according to multimodality regimens without a significant increase of treatment-associated toxicity. This five-chapter book provides examples where mAbs that have become part of the standard of care in cancer patients and cancer types that have responded to mAbs
606   $aMonoclonal antibodies$xTherapeutic use
606   $aAntibody-toxin conjugates$xTherapeutic use
606   $aCancer$xImmunotherapy
615  0$aMonoclonal antibodies$xTherapeutic use.
615  0$aAntibody-toxin conjugates$xTherapeutic use.
615  0$aCancer$xImmunotherapy.
676   $a615.37
702   $aUckun$b Fatih M.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910787593503321
996   $aMonoclonal antibodies in oncology$93730107
997   $aUNINA